References
Original patents & publications
Myelotracker :
- European Patent WO2019/115527 (DI 2011-15)
- PCTEP2018084363 (DI 2016-36)
Anderson M, Thibault Chaze C, Yves-Marie Coïc YM, Injarabian L, Jonsson F, Lombion N, Souphron J, Ridley C, Vonaesh P, Baron B, Arena ET, Tinevez JY, Nigro G, Nothelfer K, Lapierre V, Lazure T, Matondo M, Thornton D, Baleux F, Sansonetti PJ, Marteyn BS.
MUB40 binds to lactoferrin and stands as a specific neutrophil marker. Cell Chem. Biol., 2018 Apr 19;25(4):483-493
Coïc YM, Baleux F, Poyraz Ö, Thibeaux R, Labruyere E, Chretien F, Sobhani I, Lazure T, Wyplosz B, Schneider G, Mulard L, Sansonetti PJ, Marteyn BS.
Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain. J Biol Chem., 2012 May 4;287(19):15916-22
Publications using Myelotracker
Tinevez JY, Arena ET, Anderson M, Nigro G3,4, Injarabian L, André A, Ferrari M, Campbell-Valois FX, Devin A, Shorte SL, Sansonetti PJ, Marteyn BS.
Shigella-mediated oxygen depletion is essential for intestinal mucosa colonization.
Nat Microbiol., 2019 Nov;4(11):2001-2009.
Anderson MA, Injarabian L, Andre AC, Tournebize R, Marteyn BS. The MUB40 Peptide can be Used to Detect Neutrophil Mediated Inflammation Events, JOVE, 2019 Jan 7;(143)
